The entero-insular axis in polycystic ovarian syndrome

Annals of Clinical Biochemistry

Volumn 33, Issue 3, 1996, Pages 190-195

  Gama, R ^a   Norris, F ^b   Wright, J ^a,b   Morgan, L ^b   Hampton, S ^b   Watkins, K ^a   Marks, V ^a,b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

C peptide; Gastric inhibitory polypeptide; Glucagon like peptide 1; Hepatic extraction of insulin; Insulin; Polycystic ovarian syndrome; Proinsulin

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; IMMUNOREACTIVE INSULIN; INSULIN; PROINSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PANCREAS SECRETION; PRIORITY JOURNAL;

EID: 0029974347     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300303     Document Type: Article

References (46)

1. McKenna TJ. Pathogenesis and treatment of polycystic ovarian syndrome. N Eng J Med 1988; 318: 558-62
2. Nader S. Polycystic ovary syndrome and the androgen-insulin connection. Am J Obstet Gynecol 1991; 165: 346-8
3. Conway GS, Jacobs HS. Clinical implications of hyperinsulinaemia in women. Clin Endocrinol 1993; 39: 623-32
4. Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 1989; 31: 87-120
5. Pasquali R, Casimirri F. The impact of obesity in hyperandrogenism and polycystic ovarian syndrome in premenopausul women. Clin Endocrinol 1993; 39: 1-16
6. Morgan LM. The role of the entero-insular axis in insulin secretion. Biochem Soc Trans 1990; 18: 101-2
7. Creutzfeldt W, Ebert R. New development in the incretin concept. Diabetologia 1985; 28: 565-73
8. Orskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 1992; 35: 701-11
9. Alam MJ, Buchanan KD. Conflicting gastric inhibitory polypeptide data: possible causes. Diabetes Res Clin Pract 1993; 19: 93-101
10. Fukase N, Igarashi M, Takahashi H, Mananka H, Yamatani K, Daimon M, et al. Hypersecretion of truncated glucagon like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabetic Med 1993; 10: 44-9
11. Kiddy DS, Hamilton-Fairley D, Seppala M, Koistinen R, James VHT, Reed MJ et al. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: Correlation with serum insulin and insulin-like growth factor-1. Clin Endocrinol 1989; 31: 757-63
12. Sobey WJ, Beer SF, Carrington CA, Clark PMS, Frank BH, Gray IP, et al. Sensitive and specific immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 1989; 260: 535-41
13. Conway GS, Clark PM, Wong D. Hyperinsulinaemia in polycystic ovarian syndrome confirmed with a specific immunoradiometric assay for insulin. Clin Endocrinol 1993; 38: 219-22
14. Mako ME, Starr JL, Rubenstein AH. Circulating proinsulin in patients with maturity-onset diabetes. Am J Med 1972; 53: 418-27
15. Ward WK, LeCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1988; 31: 355-60
16. Temple RC, Luzio SD, Schneider AE, Carrington CA, Owens DR, Sobey WJ, et al. Insulin deficiency in non-insulin dependent diabetes. Lancet 1989; ii, 293-5
17. Dahlegren E, Johansson S, Lindsedet G, Knutsson F, Oden A, Janson PO, et al. Women with polycystic ovarian syndrome resected in 1956 1965: a long-term follow up focusing on natural history and circulating hormones. Fertil Steril 1992; 57: 505-13
18. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with polycystic ovarian syndrome. Clin Endocrinol (Oxf) 1992; 37: 119-25
19. krentz, AJ, Clark PM, Cox L, Nattrass M. Hyperproinsulinaemia in impaired glucose tolerance. Clin Sci 1993; 85: 97-100
20. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased concentrations of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabetic Med 1993; 10: 313-20
21. Gama R, Shah S, Wright J, Marks V. Hyperinsulinaemia of hypertriglyceridaemia: A reappraisal. Diabetic Med 1995; 12: 321-4
22. World Health Organization. Diabetes Mellitus. Report of a Study Group. Techn Rep Series, Geneva: WHO, 1985: 727
23. Rosner W. A simplified method for the quantitative determination of testosterone-oestradiol-binding globulin activity in human plasma. J Clin Endocrinol Metab 1972; 34: 983-8
24. Goodall, AB, Rippon AE, James VHT. A simple chromatographic radioimmunassay for plasma androstenedione. J. Steroid Biochem 1979; 11: 1181-4
25. Hampton S, Marks V. Development, validation and use of a human C-peptide radioimmunoassay. Diabetologia 1979; 17: 24-31
26. Hampton SM, Beyzavi K, Teale D, Marks V. A direct assay for proinsulin in plasma and its applications in hypoglycaemia. Clin Endocrinol 1988; 29: 9-16
27. Morgan LM, Morris BA, Marks V. Radioimmunoassay of gastric inhibitory polypeptide. Ann Clin Biochem 1978; 23: 413-24
28. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man:acute post-prandial and 24h secretion patterns. J Endocrinol 1993; 138: 159-66
29. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovarian syndrome: clinical, biochemical and ultrasound features in 556 patients. Clin Endocrinol 1989; 30: 459-70
30. Antilla L, Koskinen P, Jaatinen T, Erkkola R, Irjala K, Ruutiainen K. Insulin hypersecretion together with high luteinising hormone concentration augments androgen secretion in oral glucose test in women with polycystic ovarian disease. Hum Reprod 1993; 8: 1179-83
31. Grulet H, Hecart AC, Delemer B, Gross A, Sulmont V, Leutenegger M, Caron J. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol 1993; 38: 621-6
32. Horwitz D, Starr J, Marks M, Blankard W, Rubenstein A. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 1975; 55: 1278-86
33. Field J. Extraction of insulin by the liver. Ann Rev Med 1973; 24: 309-18
34. Gjessing HJ. C-peptide used in the estimation of islet beta-cell function in diabetes. Dan Med Bull 1992; 39: 438-52
35. Mahabeer S, Jialal I, Norman RJ, Naidoo C, Reddi K, Joubert SM. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease. Horm Metab Res 1989; 21: 502-6
36. O'Meera NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL, et al. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1241-7
37. Tropeano G, Luscisano A, Liberale I, Barini A, Vuolo IP, Martino G, et al. C-peptide, androgens and β-endorphin response to oral glucose in patients with polycystic ovarian syndrome. J Clin Endocrinol Metab 1994; 78: 305-9
38. Gama R, Marks V. The reduction in peripheral insulin secretion in obese subjects following a hypocaloric diet: Reduced pancreatic secretion or increased hepatic extraction? Ann Clin Biochem 1989; 26: 388-92
39. Faber OK, Christensen K, Kehlet H, Madsbad S, Binder C. Decreased insulin removal contributes to hyperinsulinaemia in obesity. J Clin Endocrinol Metab 1981; 53: 618-21
40. Meistas MT, Margolis S, Kowarski AA. Hyperinsulinaemia of obesity is due to decreased clearance of insulin. Am J Physiol 1983; 245: E155-E159
41. Bonara E, Zavaroni I, Coscelli C, Butturini N. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 1983; 34: 438-44
42. Hornnes PJ. Gastroentero-pancreatic hormones in pregnancy. Scand J Gastroenterol 1984; 19: 451-6
43. Marks V, Rangananthan L, Beety J, Morgan L, Howland R, Wright J. Diminished post-prandial GLP-1 secretion in obese human subjects. In: Satellite Symposium on Glucagon and Related Peptides 1994. Kobe: IDGF, 1994.
44. Watkins K. Investigation of the hyperinsulinaemia and entero-insular axis in pregnancy and gestational diabetes, [MSc thesis], Surrey: University of Surrey, 1994
45. Tronier B, Deigard A, Anderson T, Madsbad S, Absence of incretin effect in obese type 2 and diminished effect in lean type 2 and obese subjects. Diabetes Res Clin Prac 1985; Suppl 1: S568
46. Hornnes P, Kuhl C, Klebe JG. Diminished gastrointestinal potentiation of insulin secretion in human pregnancy. Diabetologia 1978: 15: 165-8